Browse Category

Stock Market Analysis News 17 December 2025 - 29 December 2025

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

NEW YORK, December 29, 2025, 10:59 ET Stock Traders Daily early on Dec. 29 published a trading-setup note on Enbridge Inc (ENB), citing an “exceptional 15.2:1” risk-reward profile for the Canadian pipeline operator’s shares. Stock Traders Daily The note matters for short-term traders because it maps out entry, target and stop-loss levels — prices where a position is cut to…
Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:42 PM ET — Market Closed U.S. equity markets are closed Sunday, leaving investors in rare metals stocks—from rare earths and graphite to lithium, antimony, silver, and platinum group metals—to digest a headline-heavy stretch that reshaped the near-term setup for the next trading session. The big picture going into Monday is a push-and-pull: a powerful…
Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 12:37 p.m. ET — Market closed. U.S. stock markets are shut for the weekend, leaving semiconductor stocks in a familiar year-end spotlight: investors are weighing bullish AI-driven demand against fresh supply-chain strain and renewed questions about how durable the “AI trade” really is. With the next regular session set for Monday, Dec. 29, chipmakers and…
Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

New York time check: It is 1:31 p.m. ET on Friday, December 26, 2025 in New York. U.S. natural gas is back in the spotlight as winter weather risk re-enters the conversation, even while Wall Street trades in a post-holiday lull near record highs. With U.S. equity benchmarks hovering close to all-time levels and trading volumes typically thinner during the…
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave of procedure growth could look like in 2026. With U.S. markets closed for Christmas Day, ISRG was last quoted around…
Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

December 25, 2025 (Thursday) — Applied Materials, Inc. is closing out the year with a familiar paradox: strong financial performance driven by AI-era semiconductor demand, paired with real policy-driven friction tied to U.S.-China export controls. With U.S. equity markets closed for Christmas Day and set to reopen Friday, December 26, investors are digesting a late-year stack of catalysts—earnings and guidance,…
Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

As the U.S. banking sector heads into year-end, Wells Fargo & Company (NYSE: WFC) is closing 2025 with a noticeably different narrative than the one investors and regulators have debated for much of the past decade: less about constraint, more about growth levers, fee momentum, and capital flexibility. The shift is being driven by a cluster of late-December developments—most notably…
Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

December 24, 2025 — Adobe Inc. (NASDAQ: ADBE) is ending the holiday-shortened Christmas Eve session in focus, as investors weigh two competing narratives: a high-margin software leader guiding to another year of growth — and a creative franchise facing louder questions about how generative AI reshapes its moat. U.S. markets are open only briefly today, closing early at 1:00 p.m.…
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely to hinge less on quarterly fundamentals and more on the probability, timing, and conditions of closing. SEC FOLD last traded…
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50 per share in cash, a premium of about 33% to Amicus’ prior close. Reuters On December 19, FOLD shares surged…
Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Dec. 20, 2025 — Real estate stocks are heading into 2026 with a familiar catalyst back in the driver’s seat: interest rates. After the Federal Reserve lowered the federal funds target range by 25 basis points to 3.5%–3.75% at its December meeting, investors are reassessing everything from REIT dividend durability to housing demand and refinancing risk. Federal Reserve But the…
20 December 2025
Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

December 17, 2025 — Micron Technology (NASDAQ: MU) is stepping into one of the most closely watched earnings prints in the semiconductor sector this quarter, as investors look for a clear read on two forces tugging the market in opposite directions: a powerful memory pricing upcycle and fresh anxiety about AI infrastructure spending discipline. Micron is scheduled to report its…
1 2 3

Stock Market Today

  • St Barbara (ASX:SBM) Shares Surge on Nova Scotia Project Study, Valuation Split Evident
    January 25, 2026, 5:57 AM EST. St Barbara (ASX:SBM) has risen sharply, gaining 8.45% in one day and 38.74% over seven days, following the completion of a Pre Feasibility Study for its 15 Mile Processing Hub Project in Nova Scotia. Despite recent losses of A$54.6 million, the company shows promise with forecasted 23.7% annual revenue growth and potential profitability within three years. The stock trades at A$0.77, above a projected fair price-to-sales (P/S) ratio of 1x, yet below the Australian metals and mining sector's average P/S of 144.6x. Valuations diverge sharply; a discounted cash flow (DCF) model suggests shares are undervalued by approximately 87% against a fair value of A$5.89. Investors face risks including operations at the Simberi mine in Papua New Guinea, but strong longer-term total shareholder returns provide context for the recent price momentum.
Go toTop